Skip to content

FLGT

Fulgent Genetics, Inc.

NASDAQ · Healthcare · Medical - Diagnostics & Research · US

$19.73
+0.41%
Ask drillr
0
Insider buys (3m)
4
Insider sells (3m)
-$117.1K
Net value (3m)
+2.1%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 3, 2026Hsieh Ming · director, 10 percent owner, officer: Chief Executive OfficerF-InKind4,392$20
Sep 3, 2026Xie Jian · officer: President and COOSale2,127$20
Sep 3, 2026Kim Paul · officer: CFO and TreasurerF-InKind2,087$20
Sep 3, 2026Gao Hanlin · officer: Chief Scientific OfficerSale1,673$20
Aug 28, 2026Kim Paul · officer: CFO and TreasurerF-InKind1,168$20
Aug 28, 2026Gao Hanlin · officer: Chief Scientific OfficerSale939$20
Aug 28, 2026Hsieh Ming · director, 10 percent owner, officer: Chief Executive OfficerF-InKind2,949$20
Aug 28, 2026Xie Jian · officer: President and COOSale1,193$20
Jul 28, 2026Kim Paul · officer: CFO and TreasurerF-InKind2,747$20
Jul 28, 2026Gao Hanlin · officer: Chief Scientific OfficerF-InKind1,645$20
Jul 28, 2026Xie Jian · officer: President and COOF-InKind4,361$20
May 28, 2026Xie Jian · officer: President and COOSale1,201$18
May 28, 2026Gao Hanlin · officer: Chief Scientific OfficerSale945$18
May 28, 2026Kim Paul · officer: CFO and TreasurerF-InKind1,168$18
May 27, 2026Hsieh Ming · director, 10 percent owner, officer: Chief Executive OfficerF-InKind2,949$18
May 18, 2026GROVES REGINA E · directorA-Award11,117$0.00
May 18, 2026Dong Linda · directorA-Award11,117$0.00
May 18, 2026Nohaile Michael · directorA-Award5,558$0.00
May 18, 2026Nohaile Michael · directorA-Award8,426$16
Apr 28, 2026Gao Hanlin · officer: Chief Scientific OfficerF-InKind1,645$16
Apr 28, 2026Kim Paul · officer: CFO and TreasurerF-InKind2,747$16
Apr 28, 2026Xie Jian · officer: President and COOF-InKind4,361$16
Mar 2, 2026Kim Paul · officer: CFO and TreasurerF-InKind8,347$15
Mar 2, 2026Kim Paul · officer: CFO and TreasurerF-InKind1,168$25
Mar 2, 2026Xie Jian · officer: President and COOF-InKind8,147$15
Mar 2, 2026Gao Hanlin · officer: Chief Scientific OfficerF-InKind897$25
Mar 2, 2026Gao Hanlin · officer: Chief Scientific OfficerF-InKind1,018$15
Mar 2, 2026Gao Hanlin · officer: Chief Scientific OfficerF-InKind6,410$15
Mar 2, 2026Hsieh Ming · director, 10 percent owner, officer: Chief Executive OfficerF-InKind17,566$15
Mar 2, 2026Kim Paul · officer: CFO and TreasurerF-InKind1,133$15
Institutional positioning

13F filings over the trailing two quarters

New 52Increased 90Reduced 111Sold out 36
FilerActionSharesFiled
BLACKROCK, INC.Reduced2,774,519May 13, 2026
BlackRock, Inc.Reduced2,286,669Aug 7, 2026
RTW INVESTMENTS, LPIncreased1,289,000May 15, 2026
ACADIAN ASSET MANAGEMENT LLCIncreased1,233,951May 13, 2026
ACADIAN ASSET MANAGEMENT LLCReduced1,017,913Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position880,150May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCReduced789,498Aug 13, 2026
JACOBS LEVY EQUITY MANAGEMENT, INCIncreased782,116Aug 14, 2026
JPMORGAN CHASE & COIncreased756,558Aug 12, 2026
Diametric Capital, LPIncreased697,784Aug 14, 2026
DIMENSIONAL FUND ADVISORS LPReduced671,664May 7, 2026
AMERIPRISE FINANCIAL INCIncreased670,084Aug 14, 2026
DIMENSIONAL FUND ADVISORS LPReduced625,355Aug 11, 2026
INVENOMIC CAPITAL MANAGEMENT LPNew Position610,318May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased584,207May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026